The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Parkinson's Disease–Associated Kinase PINK1 Regulates Miro Protein Level and Axonal Transport of Mitochondria
Open accessAbstract
Mutations in Pten-induced kinase 1 (PINK1) are linked to early-onset familial Parkinson's disease (FPD). PINK1 has previously been implicated in mitochondrial fission/fusion dynamics, quality control, and electron transport chain function. However, it is not clear how these processes are interconnected and whether they are sufficient to explain all aspects of PINK1 pathogenesis. Here we show that PINK1 also controls mitochondrial motility. In Drosophila, downregulation of dMiro or other components of the mitochondrial transport machinery rescued dPINK1 mutant phenotypes in the muscle and dopaminergic (DA) neurons, whereas dMiro overexpression alone caused DA neuron loss. dMiro protein level was increased in dPINK1 mutant but decreased in dPINK1 or dParkin overexpression conditions. In Drosophila larval motor neurons, overexpression of dPINK1 inhibited axonal mitochondria transport in both anterograde and retrograde directions, whereas dPINK1 knockdown promoted anterograde transport. In HeLa cells, overexpressed hPINK1 worked together with hParkin, another FPD gene, to regulate the ubiquitination and degradation of hMiro1 and hMiro2, apparently in a Ser-156 phosphorylation-independent manner. Also in HeLa cells, loss of hMiro promoted the perinuclear clustering of mitochondria and facilitated autophagy of damaged mitochondria, effects previously associated with activation of the PINK1/Parkin pathway. These newly identified functions of PINK1/Parkin and Miro in mitochondrial transport and mitophagy contribute to our understanding of the complex interplays in mitochondrial quality control that are critically involved in PD pathogenesis, and they may explain the peripheral neuropathy symptoms seen in some PD patients carrying particular PINK1 or Parkin mutations. Moreover, the different effects of loss of PINK1 function on Miro protein level in Drosophila and mouse cells may offer one explanation of the distinct phenotypic manifestations of PINK1 mutants in these two species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Once activated, Parkin has been reported to facilitate ubiquitination of numerous OMM proteins, including Mfn1 [126,127,128], Mfn2 [129], VDAC [130], Tom20 (translocase of the outer membrane 20) [121], and Miro [131].”
From Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Self-citationParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969
Self-citationDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
Self-citationKinesin and Dynein Superfamily Proteins and the Mechanism of Organelle Transport
Hirokawa, N. (1998) · Science · doi:10.1126/science.279.5350.519 · Cited by 1,689
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 370
Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson’s Disease
Vizziello, M., Borellini, L., Franco, G., & Ardolino, G. (2021) · Cells · doi:10.3390/cells10113022 · Cited by 104
Mitophagy and Parkinson's disease: Be eaten to stay healthy
de Vries, R. L. A., & Przedborski, S. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.008 · Cited by 96
Genes associated with Parkinson's disease: regulation of autophagy and beyond
Beilina, A. G., & Cookson, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13266 · Cited by 98
Current perspective of mitochondrial biology in Parkinson's disease
Kaidery, N. A., & Thomas, B. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.03.001 · Cited by 95
Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
Palomo, G. M., Granatiero, V., Kawamata, H., Konràd, C., Kim, M. J., Arreguin, A. J., Zhao, D., Milner, T. A., & Manfredi, G. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201808888 · Cited by 88
Wu, Z., Wang, Y., Lim, J., Liu, B., Li, Y., Vartak, R. S., Stankiewicz, T. R., Montgomery, S. B., & Lu, B. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.007 · Cited by 87
Self-citationSung, H., Tandarich, L. C., Nguyen, K. K., & Hollenbeck, P. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0633-16.2016 · Cited by 85
AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons
Amadoro, G., Corsetti, V., Florenzano, F., Atlante, A., Ciotti, M. T., Mongiardi, M. P., Bussani, R., Nicolin, V., Nori, S. L., Campanella, M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.018 · Cited by 86
Wu, Y., Yao, Y.-M., & Lu, Z. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01756-2 · Cited by 86
Großmann, D., Berenguer-Escuder, C., Bellet, M. E., Scheibner, D., Bohler, J., Massart, F., Rapaport, D., Skupin, A., d’Hérouël, A. F., Sharma, M., et al. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7718 · Cited by 86
MIRO GTPases in Mitochondrial Transport, Homeostasis and Pathology
Tang, B. L. (2015) · Cells · doi:10.3390/cells5010001 · Cited by 81
Mitophagy and Innate Immunity in Infection.
Cho, D., Kim, J. K., & Jo, E. (2020) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2020.2329 · Cited by 85
Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
Kamienieva, I., Duszyński, J., & Szczepanowska, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-020-00229-8 · Cited by 84
Calcium, Bioenergetics, and Parkinson’s Disease
Zampese, E., & Surmeier, D. J. (2020) · Cells · doi:10.3390/cells9092045 · Cited by 79
Devireddy, S., Liu, A., Lampe, T., & Hollenbeck, P. J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1198-15.2015 · Cited by 78
Corti, O., & Brice, A. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.11.002 · Cited by 79
Structural coupling of the EF hand and C‐terminal GTPase domains in the mitochondrial protein Miro
Klosowiak, J. L., Focia, P. J., Chakravarthy, S., Landahl, E. C., Freymann, D. M., & Rice, S. E. (2013) · EMBO Reports · doi:10.1038/embor.2013.151 · Cited by 78
Recent advances in Parkinson’s disease genetics
Lubbe, S. J., & Morris, H. R. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7003-2 · Cited by 81
Song, S., Jang, S., Park, J., Bang, S., Choi, S., Kwon, K., Zhuang, X., Kim, E., & Chung, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430801 · Cited by 80
Mitochondrial hexokinase HKI is a novel substrate of the Parkin ubiquitin ligase
Okatsu, K., Iemura, S., Koyano, F., Go, E., Kimura, M., Natsume, T., Tanaka, K., & Matsuda, N. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.041 · Cited by 81
Amadoro, G., Corsetti, V., Florenzano, F., Atlante, A., Bobba, A., Nicolin, V., Nori, S. L., & Calissano, P. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00018 · Cited by 77
Axon degeneration and PGC1α-mediated protection in a vertebrate model of α-synuclein toxicity
O’Donnell, K. C., Lulla, A., Stahl, M. C., Wheat, N. D., Bronstein, J. M., & Sagasti, A. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013185 · Cited by 75
Carbon black suppresses the osteogenesis of mesenchymal stem cells: the role of mitochondria
Shen, Y., Wu, L. Y., Qin, D., Xia, Y., Zhou, Z., Zhang, X., & Wu, X. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0253-5 · Cited by 74
Nicoletti, V., Palermo, G., Prete, E. D., Mancuso, M., & Ceravolo, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.636506 · Cited by 75
PINK1-Mediated Phosphorylation of Parkin Boosts Parkin Activity in Drosophila
Shiba‐Fukushima, K., Inoshita, T., Hattori, N., & Imai, Y. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004391 · Cited by 75
Self-citationLópez‐Doménech, G., Howden, J. H., Covill‐Cooke, C., Morfill, C., Patel, J. V., Bürli, R. W., Crowther, D. C., Birsa, N., Brandon, N. J., & Kittler, J. T. (2021) · The EMBO Journal · doi:10.15252/embj.2018100715 · Cited by 85
PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation
Guardia‐Laguarta, C., Liu, Y., Lauritzen, K. H., Erdjument‐Bromage, H., Martin, B. M. S., Swayne, T. C., Jiang, X., & Przedborski, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1691-18.2019 · Cited by 70
Scott, L., Dawson, V. L., & Dawson, T. M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.008 · Cited by 72
Regulation of neuronal autophagy and the implications in neurodegenerative diseases
Cai, Q., & Ganesan, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105582 · Cited by 70
Sundar, I. K., Maremanda, K. P., & Rahman, I. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.09.022 · Cited by 68
Mitochondria: key players in the neurotoxic effects of amphetamines
Barbosa, D. J., Capela, J. P., Feio‐Azevedo, R., Gomes, A., Bastos, M. D. L., & Carvalho, F. D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1478-9 · Cited by 70
Miro sculpts mitochondrial dynamics in neuronal health and disease
Devine, M. J., Birsa, N., & Kittler, J. T. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.008 · Cited by 69
Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease
Gillingwater, T. H., & Wishart, T. M. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12014 · Cited by 66
Intracellular and Intercellular Mitochondrial Dynamics in Parkinson’s Disease
Valdinocci, D., Simões, R. F., Kovářová, J., Cunha‐Oliveira, T., Neužil, J., & Pountney, D. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00930 · Cited by 69
The Links between Parkinson’s Disease and Cancer
Ejma, M., Madetko‐Alster, N., Brzecka, A., Gurański, K., Alster, P., Misiuk‐Hojło, M., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2020) · Biomedicines · doi:10.3390/biomedicines8100416 · Cited by 69
PINK1 signalling in cancer biology
O’Flanagan, C. H., & O’Neill, C. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.006 · Cited by 66
Microtubule acetylation dyshomeostasis in Parkinson’s disease
Naren, P., Khan, S. S., Tryphena, K. P., Vora, L. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00354-0 · Cited by 66
Li, L., Nadanaciva, S., Berger, Z., Shen, W., Paumier, K. L., Schwartz, J. W., Mou, K., Loos, P., Milici, A. J., Dunlop, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085815 · Cited by 64
Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson’s disease
Shiba‐Fukushima, K., Ishikawa, K., Inoshita, T., Izawa, N., Takanashi, M., Sato, S., Onodera, O., Akamatsu, W., Okano, H., Imai, Y., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx201 · Cited by 64
Self-citationThe meaning of mitochondrial movement to a neuron's life
Lovas, J. R., & Wang, X. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.007 · Cited by 66
Lysine deacetylases and mitochondrial dynamics in neurodegeneration
Guedes-Dias, P., & Oliveira, J. M. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.005 · Cited by 63
Dynamic survey of mitochondria by ubiquitin
Escobar‐Henriques, M., & Langer, T. (2014) · EMBO Reports · doi:10.1002/embr.201338225 · Cited by 61
Tsai, P.-I., Course, M. M., Lovas, J. R., Hsieh, C.-H., Babić, M., Zinsmaier, K. E., & Wang, X. (2014) · Scientific Reports · doi:10.1038/srep06962 · Cited by 57
Tissue- and Cell-Specific Mitochondrial Defect in Parkin-Deficient Mice
Damiano, M. G., Gautier, C., Bulteau, A., Ferrando-Miguel, R., Gouarné, C., Giraudon‐Paoli, M., Pruss, R. M., Auchère, F., L'Hermitte-Stead, C., Bouillaud, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099898 · Cited by 57
Son, T., Lee, D., Lee, C., Moon, G., Ha, G. E., Lee, H., Kwak, H., Cheong, E., & Kim, D. (2019) · ACS Nano · doi:10.1021/acsnano.8b08178 · Cited by 57
Wu, Z., Sawada, T., Shiba, K., Liu, S., Kanao, T., Takahashi, R., Hattori, N., Imai, Y., & Lu, B. (2013) · Genes & Development · doi:10.1101/gad.203406.112 · Cited by 59
Self-citationStructural insights into Parkin substrate lysine targeting from minimal Miro substrates
Klosowiak, J. L., Park, S. J., Smith, K. P., French, M., Focia, P. J., Freymann, D. M., & Rice, S. E. (2016) · Scientific Reports · doi:10.1038/srep33019 · Cited by 53
Altered mitochondrial dynamics as a consequence of Venezuelan Equine encephalitis virus infection
Keck, F., Brooks-Faulconer, T., Lark, T., Ravishankar, P., Bailey, C., Salvador-Morales, C., & Narayanan, A. (2017) · Virulence · doi:10.1080/21505594.2016.1276690 · Cited by 56
Stykel, M. G., Humphries, K. M., Kamski‐Hennekam, E. R., Buchner-Duby, B., Porte-Trachsel, N., Ryan, T. L., Coackley, C. L., Bamm, V. V., Harauz, G., & Ryan, S. D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109099 · Cited by 55
Mitochondrial quality control in neurodegenerative diseases
Dupuis, L. (2013) · Biochimie · doi:10.1016/j.biochi.2013.07.033 · Cited by 55
Salazar, C., Ruiz‐Hincapie, P., & Ruíz, L. M. (2018) · Cells · doi:10.3390/cells7100154 · Cited by 52
Patel, V. P., & Chu, C. T. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.024 · Cited by 51
Mitochondrial turnover and homeostasis in ageing and neurodegeneration
Markaki, M., & Tavernarakis, N. (2020) · FEBS Letters · doi:10.1002/1873-3468.13802 · Cited by 50
Evidence to support mitochondrial neuroprotection, in severe traumatic brain injury
Gajavelli, S., Sinha, V. K., Mazzeo, A. T., Spurlock, M. S., Lee, S. W., Ahmed, A. I., Yokobori, S., & Bullock, R. M. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9589-1 · Cited by 51
Self-citationMitophagy and neurodegeneration
Wager, K., & Russell, C. (2013) · Autophagy · doi:10.4161/auto.25082 · Cited by 51
Geng, Z., Guan, S., Wang, S., Yu, Z., Liu, T., Du, S., & Zhu, C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14344 · Cited by 49
The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease
Großmann, D., Berenguer-Escuder, C., Chemla, A., Arena, G., & Krüger, R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00587 · Cited by 55
Transporting mitochondria in neurons
Course, M. M., & Wang, X. (2016) · F1000Research · doi:10.12688/f1000research.7864.1 · Cited by 47
Panchal, K., & Tiwari, A. K. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.10.005 · Cited by 49
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 51
Vrijsen, S., Vrancx, C., Vecchio, M. D., Swinnen, J. V., Agostinis, P., Winderickx, J., Vangheluwe, P., & Annaert, W. G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.900338 · Cited by 53
The myriad roles of Miro in the nervous system: axonal transport of mitochondria and beyond
Lee, K., & Lu, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00330 · Cited by 46
Self-citationMills, K. M., Brocardo, M. G., & Henderson, B. R. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-09-0632 · Cited by 44
PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration
Chen, Y., Deng, J., Wang, P., Yang, M., Chen, X., Zhu, L., Liu, J., Lu, B., Shen, Y., Fushimi, K., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw310 · Cited by 46
Self-citationUnderstanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders
Kay, L., Pienaar, I. S., Cooray, R., Black, G. W., & Soundararajan, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0927-x · Cited by 44
Parrado‐Fernández, C., Schreiner, B., Ankarcrona, M., Conti, M. M., Cookson, M. R., Kivipelto, M., Cedazo-Mı́nguez, Á., & Matton, A. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13815 · Cited by 43
Jiang, X., Jin, T., Zhang, H., Miao, J., Zhao, X., Su, Y., & Zhang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4578462 · Cited by 43
Theunissen, F., West, P. K., Brennan, S. E., Petrović, B., Hooshmand, K., Akkari, P. A., Keon, M., & Guennewig, B. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00272-z · Cited by 43
Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy
Jeong, Y. Y., Han, S., Jia, N., Zhang, M., Sheshadri, P., Tammineni, P., Cheung, J., Nissenbaum, M., Baskar, S. S., Kwan, K. Y., et al. (2021) · Brain · doi:10.1093/brain/awab243 · Cited by 39
Drosophila MIC60/mitofilin conducts dual roles in mitochondrial motility and crista structure
Tsai, P.-I., Papakyrikos, A. M., Hsieh, C.-H., & Wang, X. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-03-0177 · Cited by 42
Do, J., Zwick, D. B., Kenyon, J. D., Zhong, F., Askew, D., Huang, A. Y.-C., Hof, W. V., Finney, M. R., & Laughlin, M. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-90115-8 · Cited by 43
PINK1 as a Molecular Checkpoint in the Maintenance of Mitochondrial Function and Integrity
Koh, H., & Chung, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0100-8 · Cited by 40
Dynamics of Mitochondrial Transport in Axons
Niescier, R. F., Kwak, S. K., Joo, S. H., Chang, K. T., & Min, K. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00123 · Cited by 40
PINK1-Parkin signaling in Parkinson’s disease: Lessons from Drosophila
Imai, Y. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.01.016 · Cited by 42
Self-citationMitophagy in Huntington's disease
Šonský, I., Vodička, P., Kepková, K. V., & Hansíková, H. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105147 · Cited by 42
Zhu, M., Li, X., Tian, X., & Wu, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv081 · Cited by 39
Frank, C. A., Wang, X., Collins, C. A., Rodal, A. A., Yuan, Q., Verstreken, P., & Dickman, D. K. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3261-13.2013 · Cited by 37
Bocanegra, J. L., Fujita, B. M., Melton, N. R., Cowan, J. M., Schinski, E. L., Tamir, T. Y., Major, M. B., & Quintero, O. A. (2019) · Cytoskeleton · doi:10.1002/cm.21560 · Cited by 40
Neuronal Preconditioning Requires the Mitophagic Activity of C-terminus of HSC70-Interacting Protein
Lizama, B. N., Palubinsky, A. M., Raveendran, V. A., Moore, A. M., Federspiel, J. D., Codreanu, S. G., Liebler, D. C., & McLaughlin, B. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0699-18.2018 · Cited by 37
Vimar Is a Novel Regulator of Mitochondrial Fission through Miro
Ding, L., Ye, L., Han, Y., Li, Y., Ji, X., & Liu, L. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006359 · Cited by 36
Flies with Parkinson's disease
Vanhauwaert, R., & Verstreken, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.020 · Cited by 37
A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling
Shiba-Fukushima, K., Inoshita, T., Sano, O., Iwata, H., Ishikawa, K.-I., Okano, H., Akamatsu, W., Imai, Y., & Hattori, N. (2020) · iScience · doi:10.1016/j.isci.2020.101048 · Cited by 37
Self-citationBeyond Mitophagy: Cytosolic PINK1 as a Messenger of Mitochondrial Health
Steer, E. K., Dail, M. K., & Chu, C. T. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6206 · Cited by 35
Koyano, F., Okatsu, K., Ishigaki, S., Fujioka, Y., Kimura, M., Sobue, G., Tanaka, K., & Matsuda, N. (2013) · Genes to Cells · doi:10.1111/gtc.12066 · Cited by 37
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34
RNA-Binding Proteins Implicated in Mitochondrial Damage and Mitophagy
Ravanidis, S., & Doxakis, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00372 · Cited by 37
Jęśko, H. M., Lenkiewicz, A. M., Wilkaniec, A., & Adamczyk, A. (2019) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2019-026 · Cited by 34
Gene therapy targeting mitochondrial pathway in Parkinson’s disease
Choong, C., & Mochizuki, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1616-4 · Cited by 34
Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33
Ubiquitination at the mitochondria in neuronal health and disease
Covill‐Cooke, C., Howden, J. H., Birsa, N., & Kittler, J. T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.003 · Cited by 33
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 32
Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy
Jeong, Y. Y., Han, S., Jia, N., Zhang, M., Sheshadri, P., Tammineni, P., Cheung, J., Nissenbaum, M., Baskar, S. S., Kwan, K. Y., et al. (2022) · UCL Discovery (University College London) · Cited by 32
A new method for quantifying mitochondrial axonal transport
Chen, M., Li, Y., Yang, M., Chen, X., Chen, Y., Yang, F., Lu, S., Yao, S.-Y., Zhou, T., Liu, J., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0268-3 · Cited by 35
Gawęda-Walerych, K., & Żekanowski, C. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1931 · Cited by 30
The synaptic function of LRRK2
Lee, S., Imai, Y., Gehrke, S., Liu, S., & Lu, B. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120113 · Cited by 32
Self-citationThe mitochondrial Ras-related GTPase Miro: views from inside and outside the metazoan kingdom
Yamaoka, S., & Hara‐Nishimura, I. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00350 · Cited by 30
Mitochondrial roles of the psychiatric disease risk factor DISC1.
Norkett, R., Modi, S., & Kittler, J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.12.025 · Cited by 25
Verma, M., Zhu, J., Wang, K. Z. Q., & Chu, C. T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010474 · Cited by 28
Jiao, F., Meng, L., Du, K., & Li, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01195 · Cited by 30
Double-edged alliance: mitochondrial surveillance by the UPS and autophagy
Franz, A., Kevei, É., & Hoppe, T. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.08.004 · Cited by 29
Metadata
- Authors
- Liu, S., Sawada, T., Lee, S., Yu, W., Silverio, G., Alapatt, P., Millan, I., Shen, A., Saxton, W., Kanao, T., Takahashi, R., Hattori, N., Imai, Y., & Lu, B.
- Affiliations
- Stanford Medicine (US)
- Kyoto University (JP)
- Washington University in St. Louis (US)
- University of California, Santa Cruz (US)
- Juntendo University (JP)
- Corresponding author
- Imai, Yuzuru
- Lu, Bingwei
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-01
- Volume
- 8
- Issue
- 3
- Pages
- e1002537
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3291531
- OpenAlex
- W2148819754
- Cited by
- 371
- References
- 59
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 10 · 2023: 11 · 2022: 18 · 2021: 35 · 2020: 29 · 2019: 22 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 32 · 2014: 42 · 2013: 33 · 2012: 23
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (CREST)
- Dainippon Sumitomo Pharma
- Ministry of Health, Labour and Welfare
- National Institutes of Health
- Japan Society for the Promotion of Science (23390232, 23111002, 23890206, 23790973)
- National Institute of Mental Health (R01MH080378)
- National Institute of General Medical Sciences (R01GM084947, GM084947)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054926)
- Core Research for Evolutional Science and Technology
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- PINK1, Miro1, Miro2, Parkinson's disease, mitochondrial motility, Parkin, mitophagy, mitochondrial quality control, dopaminergic neurons, motor neurons, ubiquitin-mediated proteolysis, peripheral neuropathy, Drosophila
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Autophagy, Axonal Transport, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Disease Models, Animal, Drosophila, Gene Expression Regulation, HeLa Cells, Humans, Mitochondria, Motor Neurons, Parkinson Disease, Protein Serine-Threonine Kinases, Mice, Knockout, rho GTP-Binding Proteins, Drosophila Proteins, Ubiquitin-Protein Ligases, Mutant Proteins, Mice, Dopaminergic Neurons, Proton Ionophores
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
